Tau pathology is a driver of a variety of neurodegenerative disease and in Alzheimer's disease (AD) it appears to be precipitated by the formation of amyloid-β (Aβ) aggregates. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.